Do you remember RAP when the CEO stuffed up the clinical trial in the US not once but twice (I recall you posting on that forum). Pfizer still bought the IP, they did initially tried to get it cheap but share holders weren't going to sell it that cheap so they had to double their initial offer. Why would BP care about management when their whole purpose is to buy the IP and get rid of the management which happened to RAP???
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)